BioSpace News Archive

As part of a long-standing commitment to reduce the environmental footprint of the company’s products and activities, Sanofi launched a €3 million Planet Mobilization fund to support employee ideas and projects that will further contribute to a healthier environment.

Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies to treat ocular surface diseases, today announced the expansion of its pipeline with the introduction of Enriched Tear Film (ETF™) Gene Therapy and proof-of-concept in vivo study results from its first gene therapy candidate, OC-101.

Immune thrombocytopenia is an autoimmune-mediated hematological disorder affecting the platelets. The immune system of the patient with immune thrombocytopenia produces antibodies directed against platelet antigens, causing platelet destruction and suppression of platelet production in the bone marrow cells.

Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, announces that the U.S. Food and Drug Administration has granted Priority Review for Amryt’s New Drug Application for Oleogel-S10 for the treatment of Epidermolysis Bullosa.

Consistent technological progresses in treatment administered to patients with muscular dystrophy are fueling the demand for non-hormonal steroid modulators in the market

With enhanced efficiency, fast dissolving thin films are gaining significant momentum, creating growth opportunities for oral thin films market

Afimmune, a clinical stage drug discovery company focused on the development of biologically active lipids for the treatment of cardiometabolic diseases, announced key findings with epeleuton from preclinical atherosclerosis studies.

Lundbeck today announced that new data on migraine prevention with VYEPTI® (eptinezumab-jjmr) will be presented at the 63rd Annual Scientific Meeting of the American Headache Society (AHS), taking place virtually from June 3-6, 2021

Dreamtech distributes Cardea SOLO™ ECG System in Korea through its new healthcare organization iSigNal, and lead commercial expansion in 20+ other APAC countries.

FSD Pharma Inc. is pleased to announce the appointment of Mr. Adnan Bashir as an independent member of its Board of Directors, upon the recommendation of the Company’s Compensation, Nomination and Governance Committee.